The UFHCC Topics in Cancer and Grand Rounds Seminar Series will be held online via Zoom until further notice due to COVID-19. We hope you join us as we continue to engage in academic discourse during this difficult time.
Participants will be muted upon joining the webinar — to participate in the Q&A portion, hold your spacebar down while speaking.
Matthew Cascio, D.O.| May 8: 9 – 10 a.m. | GD2 and GD3; Are They Effective Targets in Resistant Solid Tumors?
Jonathan D. Licht, M.D.| May 15: 9 – 10 a.m.
Sara A. Hurvitz, Ph.D. | May 6: 12 – 1 p.m. | From worst prognosis to best diagnosis: How targeted therapy has changed the natural history of HER2-driven breast cancer and how the field is continuing to evolve